Physician profile
Amy Levav
NPI 1982755112
$1,293.67
in general payments reported to CMS, 2019-2025
18 companies · $433 in 2025
The $433 reported for 2025 was more than what 77% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $105 · 2021: $58.89 · 2022: $167 · 2023: $386 · 2024: $143 · 2025: $433.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $963.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $963.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $434.02 | 2022-2025 | |
| Exeltis, USA INC. | $165.82 | 2019-2025 | Slynd |
| Astellas Pharma US INC | $140.05 | 2023-2025 | Veozah |
| Abbvie INC. | $71.20 | 2019-2023 | |
| Therapeuticsmd, INC. | $66.55 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $62.49 | 2019-2023 | |
| Myovant Sciences INC. | $58.34 | 2021-2022 | |
| Hologic Sales and Service, LLC | $55.42 | 2023 | Aptima, Thinprep 2000 Processor |
| Coopersurgical, INC. | $44.20 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Allergan, INC. | $33.70 | 2019 | |
| Millicent US INC | $29.39 | 2023-2024 | Femring, Intrarosa |
| Merck Sharp & Dohme LLC | $25.69 | 2023 | Gardasil 9 |
| Sumitomo Pharma America, INC. | $23.70 | 2023 | Myfembree |
| Minerva Surgical, INC | $22.18 | 2025 | |
| Pfizer INC. | $18.40 | 2024 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $17.55 | 2022 | |
| Scynexis, INC. | $14.41 | 2022 | |
| Organon LLC | $10.56 | 2023-2025 | Nexplanon, Nuvaring |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amy Levav listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.